Employees: 02 (2023.0)Legal category: 5785Size: PMECreation date: 2014-05-05 (12 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: BONIFACIO (20169), None
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE BONIFACIO : revenue, balance sheet and financial ratios
PHARMACIE DE BONIFACIO is a French company
founded 12 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in BONIFACIO (20169),
this company of category PME
shows in 2022 a net income positive of 483 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE BONIFACIO (SIREN 802089243)
Indicator
2022
2021
2020
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
Net income
483 118 €
601 598 €
249 826 €
355 034 €
306 601 €
295 273 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2022, PHARMACIE DE BONIFACIO generates positive net income of 483 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2022: 295 k€ -> 483 k€.
Net income (2022)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
483 118 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 47%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 60%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2022)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
46.858%
Financial autonomy (2022)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
60.203%
Asset age ratio (2022)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE BONIFACIO
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2020
2021
2022
Debt ratio
342.493
211.019
145.245
110.924
61.281
46.858
Financial autonomy
20.074
28.248
36.541
42.172
51.877
60.203
Repayment capacity
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
46.862022
2020
2021
2022
Q1: 24.5
Med: 74.73
Q3: 182.59
Good-16 pts over 3 years
In 2022, the debt ratio of PHARMACIE DE BONIFACIO (46.86) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
60.2%2022
2020
2021
2022
Q1: 28.53%
Med: 47.06%
Q3: 66.62%
Good+16 pts over 3 years
In 2022, the financial autonomy of PHARMACIE DE BONIFACIO (60.2%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 297.83. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2022)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
297.829
Liquidity indicators evolution PHARMACIE DE BONIFACIO
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2020
2021
2022
Liquidity ratio
226.366
241.259
324.79
340.133
236.752
297.829
Interest coverage
None
None
None
None
None
None
Sector positioning
Liquidity ratio
297.832022
2020
2021
2022
Q1: 145.2
Med: 199.49
Q3: 275.01
Excellent
In 2022, the liquidity ratio of PHARMACIE DE BONIFACIO (297.83) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Positioning of PHARMACIE DE BONIFACIO in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 215 transactions of similar company sales
in 2022,
the value of PHARMACIE DE BONIFACIO is estimated at
5 684 612 €
(range 3 821 188€ - 8 525 862€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2022
215 transactions
3821k€5684k€8525k€
5 684 612 €Range: 3 821 188€ - 8 525 862€
NAF 5 année 2022
Valuation method used
Net Income Multiple
483 118 €
×
11.8x
=5 684 612 €
Range: 3 821 189€ - 8 525 863€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 215 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE BONIFACIO with other companies in the same sector:
Frequently asked questions about PHARMACIE DE BONIFACIO
What is the revenue of PHARMACIE DE BONIFACIO ?
The revenue of PHARMACIE DE BONIFACIO is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DE BONIFACIO profitable?
Yes, PHARMACIE DE BONIFACIO generated a net profit of 483 k€ in 2022.
Where is the headquarters of PHARMACIE DE BONIFACIO ?
The headquarters of PHARMACIE DE BONIFACIO is located in BONIFACIO (20169).
Where to find the tax return of PHARMACIE DE BONIFACIO ?
The tax return of PHARMACIE DE BONIFACIO is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE BONIFACIO operate?
PHARMACIE DE BONIFACIO operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart